These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21810601)

  • 1. Pleiotropic effects of GIP on islet function involve osteopontin.
    Lyssenko V; Eliasson L; Kotova O; Pilgaard K; Wierup N; Salehi A; Wendt A; Jonsson A; De Marinis YZ; Berglund LM; Taneera J; Balhuizen A; Hansson O; Osmark P; Dunér P; Brøns C; Stancáková A; Kuusisto J; Bugliani M; Saxena R; Ahlqvist E; Kieffer TJ; Tuomi T; Isomaa B; Melander O; Sonestedt E; Orho-Melander M; Nilsson P; Bonetti S; Bonadonna R; Miccoli R; Delprato S; Marchetti P; Madsbad S; Poulsen P; Vaag A; Laakso M; Gomez MF; Groop L
    Diabetes; 2011 Sep; 60(9):2424-33. PubMed ID: 21810601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of circulating GIP and GLP-1 concentrations.
    Almgren P; Lindqvist A; Krus U; Hakaste L; Ottosson-Laakso E; Asplund O; Sonestedt E; Prasad RB; Laurila E; Orho-Melander M; Melander O; Tuomi T; Holst JJ; Nilsson PM; Wierup N; Groop L; Ahlqvist E
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D; Seino Y
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link between GIP and osteopontin in adipose tissue and insulin resistance.
    Ahlqvist E; Osmark P; Kuulasmaa T; Pilgaard K; Omar B; Brøns C; Kotova O; Zetterqvist AV; Stancáková A; Jonsson A; Hansson O; Kuusisto J; Kieffer TJ; Tuomi T; Isomaa B; Madsbad S; Gomez MF; Poulsen P; Laakso M; Degerman E; Pihlajamäki J; Wierup N; Vaag A; Groop L; Lyssenko V
    Diabetes; 2013 Jun; 62(6):2088-94. PubMed ID: 23349498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of GIP in α-cells and glucagon secretion.
    El K; Campbell JE
    Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet.
    Lewandowski SL; El K; Campbell JE
    Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E103-E110. PubMed ID: 38775725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide.
    Khan R; Tomas A; Rutter GA
    Peptides; 2020 Mar; 125():170201. PubMed ID: 31751656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCF1 links GIPR signaling to the control of beta cell function and survival.
    Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
    Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
    Pathak V; Vasu S; Flatt PR; Irwin N
    Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function.
    Renner S; Fehlings C; Herbach N; Hofmann A; von Waldthausen DC; Kessler B; Ulrichs K; Chodnevskaja I; Moskalenko V; Amselgruber W; Göke B; Pfeifer A; Wanke R; Wolf E
    Diabetes; 2010 May; 59(5):1228-38. PubMed ID: 20185813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant.
    Yammine L; Picatoste B; Abdullah N; Leahey RA; Johnson EF; Gómez-Banoy N; Rosselot C; Wen J; Hossain T; Goncalves MD; Lo JC; Garcia-Ocaña A; McGraw TE
    Mol Metab; 2023 Dec; 78():101831. PubMed ID: 37925022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice.
    Sridhar A; Khan D; Babu G; Irwin N; Gault VA; Flatt PR; Moffett CR
    Peptides; 2024 Aug; 178():171254. PubMed ID: 38815655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.
    Puddu A; Sanguineti R; Montecucco F; Viviani GL
    J Diabetes Res; 2015; 2015():326359. PubMed ID: 26221611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.
    Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K
    Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
    Lynn FC; Pamir N; Ng EH; McIntosh CH; Kieffer TJ; Pederson RA
    Diabetes; 2001 May; 50(5):1004-11. PubMed ID: 11334402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress.
    Vasu S; Moffett RC; Thorens B; Flatt PR
    PLoS One; 2014; 9(6):e101005. PubMed ID: 24967820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.